Assets تغيير تاريخ
Acadia Pharmaceuticals USD 748.96M 116.42M 2023-12
Acorda Therapeutics USD 364.7M 10.21M 2023-06
Alnylam Pharmaceuticals USD 3.83B 9.19M 2023-12
Amarin USD 839.03M 20.99M 2023-09
Amgen USD 97.15B 6.62B 2023-12
Arrowhead Research USD 626.29M 139.27M 2023-12
AstraZeneca USD 96.09B 457M 2023-09
Biogen USD 26.84B 1.35B 2023-12
Bluebird Bio USD 613.61M 49.78M 2023-09
Bristol-Myers Squibb USD 91.26B 2.23B 2023-09
Eli Lilly USD 57.92B 3.1B 2023-09
Enanta Pharmaceuticals USD 462.28M 32.89M 2023-09
Esperion Therapeutics USD 221.3M 13.32M 2023-09
Galectin Therapeutics USD 22.16M 2.08M 2023-09
Gilead Sciences USD 62.13B 248M 2023-12
GlaxoSmithKline GBP 60.86B 1.4B 2023-09
Incyte USD 6.78B 393.87M 2023-12
Ionis Pharmaceuticals USD 2.99B 56.1M 2023-12
Moderna USD 18.43B 1.02B 2023-12
Neurocrine Biosciences USD 2.85B 235.1M 2023-09
PTC Therapeutics USD 1.9B 635.81M 2023-12
Regeneron Pharmaceuticals USD 33.08B 916.9M 2023-12
Sarepta Therapeutics USD 3.11B 16.18M 2023-09
Vertex Pharmaceuticals USD 21.73B 1.38B 2023-09



Intercept Pharmaceuticals الأصول - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2024.